GENEVA, Oct. 19 -- ILLIMIS THERAPEUTICS, INC. (2Floor, 18 Heolleung-ro 569-gil,Gangnam-gu,Seoul 06376), 일리미스테라퓨틱스 주식회사 (서울특별시강남구헌릉로569길 18, 2층), KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (291 Daehak-ro,Yuseong-gu,Daejeon 34141), 한국과학기술원 (대전광역시유성구대학로 291) filed a patent application (PCT/KR2025/004931) for "ERBB4-TARGETING COMPOSITION FOR PREVENTING, TREATING OR DIAGNOSING NEURODEGENERATIVE DISEASES" on Apr 11, 2025. With publicati...